AVBP

ARRIVENT BIOPHARMA INC

AVBP·04272N102·US·Common Stock·Healthcare - Biotechnology-Activist

AVBP (ARRIVENT BIOPHARMA INC) is held by 94 institutional investors as of Q2 2026. Largest holders: HHLR ADVISORS, LTD. ($136.5M), BlackRock, Inc. ($112.9M), FMR LLC ($96.5M). Net institutional sentiment: Bullish.

94
Holders
(7 Elite)
$772.2M
Total Value
74% (95)
Consensus
70 buying - 25 selling
13F: Insider & Congress: Updated regularly
AVBP

Smart Money Verdict

View all
Loading verdict
Held by 94 funds
7 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Jul 27, 2026 · Congress none

ActivistBlackRock, Inc.BlackRock, Inc.6.8%Jul 27, 2026
ActivistFMR LLCFMR LLC6.8%May 6, 2026
ActivistSVSofinnova Venture Partners XI, L.P. ("SVP XI")4.1%Mar 5, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
3.9M$136.5M16.4%+73.53%
0
Increased
3.3M(+28.5%)$112.9M0.0%+13.93%
38
Decreased
2.8M(-7.9%)$96.5M0.0%+33.94%
0
Increased
1.8M(+16.1%)$61.7M0.0%+22.42%
34
Increased
1.7M(+19.1%)$58.8M0.0%+27.30%
35
Increased
972,626(+21.0%)$33.8M0.0%+34.61%
35
Increased
872,011(+136.4%)$30.3M0.0%+6.24%
46
Increased
853,723(+0.0%)$29.7M0.0%+40.91%
29
Decreased
566,796(-24.2%)$19.7M0.0%+35.35%
0
Increased
438,664(+3.0%)$15.2M0.0%+45.13%
29
Decreased
438,594(-9.8%)$15.2M0.0%+63.34%
0
Decreased
395,447(-7.2%)$13.7M0.0%+31.87%
0
Increased
381,589(+112.0%)$13.3M0.0%+8.71%
45
Increased
335,320(+32.1%)$11.6M0.0%+17.23%
36
Increased
332,753(+23.8%)$11.6M0.0%+30.08%
34
Increased
294,224(+13.7%)$10.2M0.0%+39.90%
31
Increased
259,290(+19.4%)$9M0.0%+21.19%
33
Increased
211,509(+67.2%)$7.3M0.0%+11.68%
40
Increased
189,910(+47.7%)$6.6M0.0%+24.78%
37
Increased
174,866(+118.0%)$6.1M0.0%+5.26%
44

Showing 1-20 of 101

1 / 6
AVBPAVBPARRIVENT BIOPHARMA INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used